https://www.selleckchem.com/products/amg-232.html
ointima formation secondary to vascular injury and stent implantation. The aim of this study was to evaluate both analytical characteristics and clinical results of a new chemiluminescent method for the measurement of cardiac troponin I (cTnI), named VITROS ® High Sensitivity Troponin I Assay, using the VITROS® 3600 automated platform. The results found with this new method were compared to those observed with hs-cTnI ARCHITECT and ECLIA hs-cTnT ELECSYS methods. For evaluation of analytical performance and comparison of clinical results
Like
Comment
Share
